Literature DB >> 22248870

Dual chamber pacing relieves obstruction in Japanese-variant hypertrophic cardiomyopathy.

Omar Wever-Pinzon1, Jorge Romero, Juan P Cordova.   

Abstract

Japanese-variant or apical hypertrophic cardiomyopathy (HCM) is a specific type of HCM, first described in Japan and initially thought to carry a benign prognosis. However, current evidence suggests that these patients experience severe symptoms and are at increased risk of ventricular arrhythmias and death, especially in the presence of an apical akinetic chamber. The management of patients who do not respond to medical therapy is challenging. We describe a patient with Japanese-variant HCM, with an apical akinetic chamber and severe symptoms who failed medical therapy. The use of dual chamber pacing relieved obstruction and significantly improved the patient's symptoms.

Entities:  

Mesh:

Year:  2013        PMID: 22248870      PMCID: PMC3672355          DOI: 10.1097/MJT.0b013e31821109ff

Source DB:  PubMed          Journal:  Am J Ther        ISSN: 1075-2765            Impact factor:   2.688


  5 in total

1.  Ventricular pacing with premature excitation for treatment of hypertensive-cardiac hypertrophy with cavity-obliteration.

Authors:  D A Kass; C H Chen; M W Talbot; C E Rochitte; J A Lima; R D Berger; H Calkins
Journal:  Circulation       Date:  1999-08-24       Impact factor: 29.690

2.  Ventricular tachyarrhythmia associated with hypertrophic cardiomyopathy: incidence, prognosis, and relation to type of hypertrophy.

Authors:  Hiroshi Furushima; Masaomi Chinushi; Kenichi Iijima; Akiko Sanada; Daisuke Izumi; Yukio Hosaka; Yoshifusa Aizawa
Journal:  J Cardiovasc Electrophysiol       Date:  2010-09

Review 3.  Pathophysiology and treatment of hypertrophic cardiomyopathy.

Authors:  Mark V Sherrid
Journal:  Prog Cardiovasc Dis       Date:  2006 Sep-Oct       Impact factor: 8.194

4.  Dual chamber pacemaker therapy for mid-cavity obstructive hypertrophic cardiomyopathy.

Authors:  D Begley; S Mohiddin; L Fananapazir
Journal:  Pacing Clin Electrophysiol       Date:  2001-11       Impact factor: 1.976

5.  Severe symptoms in mid and apical hypertrophic cardiomyopathy.

Authors:  Ajay Shah; Karl Duncan; Glenda Winson; Farooq A Chaudhry; Mark V Sherrid
Journal:  Echocardiography       Date:  2009-09       Impact factor: 1.724

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.